UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 639

Sortiert nach

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (S1), p.61-70

Perou, Charles M.

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2010-11, Vol.15 (S5), p.39-48

Perou, Charles M.

2010

Link zum Volltext

Verfügbarkeit prüfen

Deconstructing the molecular portraits of breast cancer

Molecular oncology, 2011-02, Vol.5 (1), p.5-23

2011

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of breast cancer as a therapeutic roadmap

Cancer discovery, 2013-01, Vol.3 (1), p.27-34

2013

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Breast cancer research : BCR, 2010-09, Vol.12 (5), p.R68-R68, Article R68

2010

Link zum Volltext

Verfügbarkeit prüfen

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

Nature genetics, 2014-10, Vol.46 (10), p.1051-1059

2014

Link zum Volltext

Verfügbarkeit prüfen

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Radiology, 2016-11, Vol.281 (2), p.382

2016

Link zum Volltext

Verfügbarkeit prüfen

Practical implications of gene-expression-based assays for breast oncologists

Nature reviews. Clinical oncology, 2012-01, Vol.9 (1), p.48-57

2012

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2013-02, Vol.18 (2), p.123-133

2013

Link zum Volltext

Verfügbarkeit prüfen

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Cell reports (Cambridge), 2015-12, Vol.13 (11), p.2353-2361

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Journal of clinical oncology, 2013-01, Vol.31 (2), p.203-209

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

PloS one, 2012-05, Vol.7 (5), p.e36530-e36530

2012

Link zum Volltext

Verfügbarkeit prüfen

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Nature communications, 2018-03, Vol.9 (1), p.1059-14, Article 1059

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1168-1176

2009

Link zum Volltext

Verfügbarkeit prüfen

A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis

Nature (London), 2015-04, Vol.520 (7547), p.358-362

2015

Link zum Volltext

Verfügbarkeit prüfen

A framework for transcriptome-wide association studies in breast cancer in diverse study populations

Genome Biology, 2020-02, Vol.21 (1), p.42-42, Article 42

2020

Link zum Volltext

Verfügbarkeit prüfen

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

Clinical cancer research, 2008-03, Vol.14 (5), p.1368-1376

2008

Link zum Volltext

Verfügbarkeit prüfen

MapSplice: accurate mapping of RNA-seq reads for splice junction discovery

Nucleic acids research, 2010-10, Vol.38 (18), p.e178

2010

Link zum Volltext

Verfügbarkeit prüfen

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity

Biomaterials, 2016-09, Vol.101, p.296-309

2016

Link zum Volltext

Verfügbarkeit prüfen

Allele-specific copy number analysis of tumors

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (39), p.16910-16915

2010

Link zum Volltext

Verfügbarkeit prüfen

ABRA: improved coding indel detection via assembly-based realignment

Bioinformatics (Oxford, England), 2014-10, Vol.30 (19), p.2813-2815

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 639

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(623)
Mit Volltextzugriff
(603)

Publikationsform

Sprache

Englisch
(638)
Japanisch
(165)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Molecular Stratification of Triple‐Negative Breast Cancers

Molecular Stratification of Triple‐Negative Breast Cancers

Deconstructing the molecular portraits of breast cancer

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

The genomic landscape of breast cancer as a therapeutic roadmap

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Practical implications of gene-expression-based assays for breast oncologists

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis

A framework for transcriptome-wide association studies in breast cancer in diverse study populations

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

MapSplice: accurate mapping of RNA-seq reads for splice junction discovery

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity

Allele-specific copy number analysis of tumors

ABRA: improved coding indel detection via assembly-based realignment

Suchergebnisse filtern